Kinnate Biopharma Inc. (KNTE) - News

13 Hot Penny Stocks To Buy According to Hedge Funds

The overall market optimism helped by expectations that the Fed might start cutting interest rates in 2024 is helping riskier assets and equities, including small-cap stocks, penny stocks and cryptocurrencies...

Keep Reading →

December 6th, 2023 - Hedge Funds News

11 Stocks with Heavy Insider Buying in 2023

Insider trading activity has always invited interest and controversy from investors and authorities.

Keep Reading →

May 22nd, 2023 - Hedge Funds Insider Trading News

Harvard University's Latest Portfolio: 10 Best Biotech Stock Picks

In this article, we will look at Harvard University's latest stock portfolio and list its 10 best biotech stock picks.

Keep Reading →

September 15th, 2022 - Hedge Funds News

Hedge Fund and Insider Trading News: David Rosen, David Einhorn, Carl Icahn, Brevan Howard Asset Management, Man Group, Archegos Capital Management, Kinnate Biopharma Inc (KNTE), and More

David Einhorn enjoyed a strong fourth quarter as his hedge fund Greenlight Capital outperformed the S&P 500's 11% gain by returning 18.6%, according to the billionaire investor's latest 13F filing.

Keep Reading →

February 16th, 2022 - Hedge Funds Insider Trading

Is Kinnate Biopharma Inc. (KNTE) A Good Stock To Buy?

In this article you are going to find out whether hedge funds think Kinnate Biopharma Inc. (NASDAQ:KNTE) is a good investment right now.

Keep Reading →

July 28th, 2021 - Hedge Funds News